Search

everythinglearnresearchcommunity

for

Search:↓

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Testosterone helps human pancreatic cells increase insulin release.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Finasteride, a hair loss medication, may be linked to stroke in young men.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

PCOS treatment should be personalized based on its type and the patient's reproductive goals.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Adult female acne is complex and requires a combination of treatments for effective management.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.